Current Cardiology Reports

, 21:7 | Cite as

Echocardiographic Findings in Cardiac Amyloidosis: Inside Two-Dimensional, Doppler, and Strain Imaging

  • Dalia Di NunzioEmail author
  • Antonino Recupero
  • Cesare de Gregorio
  • Concetta Zito
  • Scipione Carerj
  • Gianluca Di Bella
Echocardiography (JM Gardin and AH Waller, Section Editors)
Part of the following topical collections:
  1. Topical Collection on Echocardiography


Purpose of Review

The aim is to provide a description of the most important echocardiographic features in systemic amyloidosis.

Recent Findings

Amyloidosis is a heterogeneous group of multisystem disorders, characterized by an extracellular deposition of amyloid fibrils. Several imaging tests are available for the diagnosis; however, echocardiography is the cornerstone of the non-invasive imaging modality for cardiac amyloidosis. So far, little is known about the diagnosis of cardiac amyloidosis through imaging modalities.


We summarized the most important echocardiographic findings in cardiac amyloidosis. Hence, we offered a systematic report of the diagnostic performance of cardiac amyloidosis using echocardiography.


Cardiac amyloidosis Echocardiography Infiltrative cardiomyopathy Heart failure Left ventricular function Diagnosis 


Compliance with Ethical Standards

Conflict of Interest

Dalia Di Nunzio, Antonino Recupero, Cesare de Gregorio, Concetta Zito, Scipione Carerj, and Gianluca Di Bella declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.


Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Primer on the rheumatic diseases. In JohnH. Klippel, John H. Stone, L Eslie J. Crofford, Patience H. White. Patience H. White, editors. 28th chapter. Springer-Verlag New York. 2008Google Scholar
  2. 2.
    Mazzeo A, Russo M, Di Bella G, Minutoli F, Stancanelli C, Gentile L, et al. Transthyretin-related familial amyloid polyneuropathy (TTR-FAP): a single-center experience in Sicily, an Italian endemic area. J Neuromuscul Dis. 2015;2(s2):S39–48.CrossRefGoogle Scholar
  3. 3.
    Russo M, Mazzeo A, Stancanelli C, Di Leo R, Gentile L, Di Bella G, et al. Transthyretin-related familial amyloidotic polyneuropathy: description of a cohort of patients with Leu64 mutation and late onset. J Peripher Nerv Syst. 2012;17(4):385–90.CrossRefGoogle Scholar
  4. 4.
    Banypersad SM, Moon JC, Whelan C, Hawkins PN, Wechalekar AD. Updates in cardiac amyloidosis: a review. J Am Heart Assoc. 2012;1:e000364 originally published April 23, 2012.CrossRefGoogle Scholar
  5. 5.
    Flodrova P, Flodr P, Pika T, Vymetal J, Holub D, Dzubak P, et al. Cardiac amyloidosis: from clinical suspicion to morphological diagnosis. Pathology. 2018 Apr;50(3):261–8.CrossRefGoogle Scholar
  6. 6.
    Knight DS,Zumbo G, Barcella W, Steeden JA, Muthurangu V, Martinez-Naharro A, Treibel TA, Abdel-Gadir, et al. Cardiac structural and functional consequences of amyloid deposition by cardiac magnetic resonance and echocardiography and their prognostic roles. JACC Cardiovasc Imaging. 2018.Google Scholar
  7. 7.
    Mohty D, Damy T, Cosnay P, Echahidi N, Casset-Senon D, Virot P, et al. Cardiac amyloidosis: updates in diagnosis and management. Arch Cardiovasc Dis. 2013;106(10):528–40.CrossRefGoogle Scholar
  8. 8.
    Kotecha T, Martinez-Naharro A, Treibel TA, Francis R, Nordin S, Abdel-Gadir A, et al. Myocardial edema and prognosis in amyloidosis. J Am Coll Cardiol. 2018;71(25):2919–31.CrossRefGoogle Scholar
  9. 9.
    • Stancanelli C, Gentile L, Di Bella G, Minutoli F, Russo M, Vita G, et al. Phenotypic variability of TTR Val122Ile mutation: a Caucasian patient with axonal neuropathy and normal heart. Neurol Sci. 2017;38(3):525–6 This study shows some phenotypical features of TTR amyloidosis. CrossRefGoogle Scholar
  10. 10.
    •• Rapezzi C, Merlini G, Quarta CC, Riva L, Longhi S, Leone O, et al. Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types. Circulation. 2009;120:1203–12 This study provides a global description of systemic cardiac amyloidosis. CrossRefGoogle Scholar
  11. 11.
    Mesquita ET, Jorge AJL, Junior CVS, de Andrade TR. Cardiac amyloidosis and its new clinical phenotype: heart failure with preserved ejection fraction. Arq Bras Cardiol. 2017;109(1):71–80.PubMedPubMedCentralGoogle Scholar
  12. 12.
    Ruberg FL. Cardiac amyloidosis: a zebra hiding in plain sight? Circ Cardiovasc Imaging. 2017;10:e006186.CrossRefGoogle Scholar
  13. 13.
    •• Vogelsberg H, Mahrholdt H, Deluigi CC, Yilmaz A, Greulich S, et al. Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy. J Am Coll Cardiol. 2008;51(10):1022–30 This study is important because shows the diagnostic power of cardiac magnetic resonance in amyloidosis. CrossRefGoogle Scholar
  14. 14.
    • Di Bella G, Minutoli F, Mazzeo A, Vita G, Oreto G, Carerj S, et al. MRI of cardiac involvement in transthyretin familial amyloid polyneuropathy. AJR Am J Roentgenol. 2010;195:W394–9 This study demonstrates the diagnostic importance of MRI in cardiac amyloidosis. CrossRefGoogle Scholar
  15. 15.
    • Minutoli F, Di Bella G, Mazzeo A, Donato R, Russo M, Scribano E, et al. Comparison between (99m)Tc-diphosphonate imaging and MRI with late gadolinium enhancement in evaluating cardiac involvement in patients with transthyretin familial amyloid polyneuropathy. AJR Am J Roentgenol. 2013;200(3):W256–65 The study provides a view of two diagnostic tools in cardiac amyloidosis. CrossRefGoogle Scholar
  16. 16.
    Maceira AM, Prasad SK, Hawkins PN, Roughton M, Pennell DJ. Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis. J Cardiovasc Magn Reson. 2008;10:54.CrossRefGoogle Scholar
  17. 17.
    Jason N. Dungu, Oswaldo Valencia, Jennifer H. Pinney, Simon D.J. Gibbs, Dorota Rowczenio, Janet A. Gilbertson, Helen J. Lachmann, et al. CMR-Based Differentiation of AL and ATTR Cardiac Amyloidosis. JACC: Cardiovascular Imaging. 2014;7(2):133–142).Google Scholar
  18. 18.
    Minutoli F, Di Bella G, Sindoni A, Vita G, Baldari S. Effectiveness of skeletal scintigraphy in transthyretin-related amyloidosis. Int J Cardiol. 2013;168(5):4988–9.CrossRefGoogle Scholar
  19. 19.
    •• Bokhari S, Castanõ A, Pozniakoff T, Deslisle S, Latif F, Maurer MS. (99m) Tcpyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses. Circ Cardiovasc Imaging. 2013;6:195–201 This study provides the way for differentiating the various types of amyloidosis. CrossRefGoogle Scholar
  20. 20.
    Bokhari S, Castaño A, Pozniakoff T, Deslisle S, Latif F, Maurer MS. 99mTc-Pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidosis. Circ Cardiovasc Imaging. 2013;6(2):195–201.CrossRefGoogle Scholar
  21. 21.
    • Quarta CC, Solomon SD, Uraizee I, Kruger J, Longhi S, Ferlito M, et al. Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis. Circulation. 2014;129:1840–9 This study provides a differentiation of two types of Cardiac Amyloidosis. CrossRefGoogle Scholar
  22. 22.
    •• Cacciapuoti F. The role of echocardiography in the non-invasive diagnosis of cardiac amyloidosis. J Echocardiogr. 2015;13(3):84–9. In this review the most common echocardiographic features of CA are summarised. CrossRefPubMedGoogle Scholar
  23. 23.
    Siqueira-Filho AG, Cunha CL, Tajik AJ, Seward JB, Schattenberg TT, Giuliani ER. M-mode and two-dimensional echocardiographic features in cardiac amyloidosis. Circulation. 1981;63:188–96.CrossRefGoogle Scholar
  24. 24.
    •• Di Bella G, Pizzino F, Minutoli F, Zito C, Donato R, Dattilo G, et al. The mosaic of the cardiac amyloidosis diagnosis: role of imaging in subtypes and stages of the disease. Eur Heart J Cardiovasc Imaging. 2014;15(12):1307–15 The review depicts the changes in cardiac imaging among the different stages of the disease. CrossRefGoogle Scholar
  25. 25.
    Koyama J, Davidoff R, Falk RH. Longitudinal myocardial velocity gradient derived frompulsed Doppler tissue imaging in AL amyloidosis: a sensitive indicator of systolic and diastolic dysfunction. J Am Soc Echocardiogr. 2004;17:36–44.CrossRefGoogle Scholar
  26. 26.
    Koyama J, Ray-Sequin PA, Falk RH. Longitudinal myocardial function assessed by tissue velocity, strain, and strain rate tissue Doppler echocardiography in patients with AL (primary) cardiac amyloidosis. Circulation. 2003;107:2446–52.CrossRefGoogle Scholar
  27. 27.
    Bellavia D, Pellikka PA, Abraham TP, Al-Zahrani GB, Dispenzieri A, Oh JK, et al. Evidence of impaired left ventricular systolic function by Doppler myocardial imaging in patients with systemic amyloidosis and no evidence of cardiac involvement by standard two-dimensional and Doppler echocardiography. Am J Cardiol. 2008;101:1039–45.CrossRefGoogle Scholar
  28. 28.
    Di Bella G, Minutoli F, Piaggi P, Casale M, Mazzeo A, Zito C, et al. Usefulness of combining electrocardiographic and echocardiographic findings and brain natriuretic peptide in early detection of cardiac amyloidosis in subjects with transthyretin gene mutation. Am J Cardiol. 2015;116(7):1122–7.CrossRefGoogle Scholar
  29. 29.
    • Carroll JD, Gaasch WH, McAdam KP. Amyloid cardiomyopathy: characterization by a distinctive voltage/mass relation. Am J Cardiol. 1982;49(1):9–13 The review explains the differences in the structure of the left ventricular hypertrophy.CrossRefGoogle Scholar
  30. 30.
    •• Cacciapuoti F. The role of echocardiography in the non-invasive diagnosis of cardiac amyloidosis. J Echocardiogr. 2015;13(3):84–9 This is a complete review of the diagnostic power of echocardiography in amyloidosis.CrossRefGoogle Scholar
  31. 31.
    •• Koyama J, Ray-Sequin PA, Falk RH. Prognostic significance of ultrasound myocardial tissue characterization in patients with cardiac amyloidosis. Circulation. 2002;106(5):556–61 This study demonstrates that myocardial tissue plays a diagnostic and prognostic role in cardiac amyloidosis.CrossRefGoogle Scholar
  32. 32.
    • Tei C, Dujardin KS, Hodge DO, Kyle RA, Tajik AJ, Seward JB. Doppler index combining systolic and diastolic myocardial performance: clinical value in cardiac amyloidosis. J Am Coll Cardiol. 1996;28(3):658–64 This is one of the most complete study about the diastolic disfunction in cardiac amyloidosis. CrossRefGoogle Scholar
  33. 33.
    Klein AL, Hatle LK, Burstow DJ, et al. Doppler characterization of left ventricular diastolic function in cardiac amyloidosis. J Am Coll Cardiol. 1989;1(3):1017–26.CrossRefGoogle Scholar
  34. 34.
    •• Koyama J, Ray-Sequin PA, Falk RH. Longitudinal myocardial function assessed by tissue velocity, strain, and strain rate tissue Doppler echocardiography in patients with AL (primary) cardiac amyloidosis. Circulation. 2003;107:2446–52 This is a complete view about longitudinal ventricular function in patients with cardiac amyloidosis. CrossRefGoogle Scholar
  35. 35.
    • Di Bella G, Minutoli F, Piaggi P, Casale M, Mazzeo A, Zito C, et al. Quantitative comparison between amyloid deposition detected by (99m)Tc-diphosphonate imaging and myocardial deformation evaluated by strain echocardiography in transthyretin-related cardiac amyloidosis. Circ J. 2016;80(9):1998–2003 This study provides a multiparametric description of the amyloid deposition. CrossRefGoogle Scholar
  36. 36.
    • Di Bella G, Minutoli F, Pingitore A, Zito C, Mazzeo A, Aquaro GD, et al. Endocardial and epicardial deformations in cardiac amyloidosis and hypertrophic cardiomyopathy. Circ J. 2011;75(5):1200–8 The review specifies the different motion of epicardial end endocardial layers. CrossRefGoogle Scholar
  37. 37.
    Bellavia D, Abraham TP, Pellikka PA, Al-Zahrani GB, Dispenzieri A, Oh JK, et al. Detection of left ventricular systolic dysfunction in cardiac amyloidosis with strain rate echocardiography. J Am Soc Echocardiogr. 2007;20(10):1194–202.CrossRefGoogle Scholar
  38. 38.
    Belkin RN, Kupersmith AC, Kalique O, et al. A novel two-di- mensional echocardiographic finding in cardiac amyloidosis. Echocardiography. 2010;27:1171–6.CrossRefGoogle Scholar
  39. 39.
    •• Phelan D, Collier P, Thavendiranathan P, Popović ZB, Hanna M, Plana JC, et al. Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis. Heart. 2012;98:1442–8 This is a complete and detailed view about apical sparing in cardiac amyloidosis. CrossRefGoogle Scholar
  40. 40.
    Lee GY, Kim HK, Choi JO, Chang SA, Oh JK, Jeon ES, et al. Visual assessment of relative apical sparing pattern is more useful than quantitative assessment for diagnosing cardiac amyloidosis in borderline or mildly increased left ventricular wall thickness. Circ J. 2015;79(7):1575–84.CrossRefGoogle Scholar
  41. 41.
    Austin BA, Tang WH, Rodriguez ER, et al. Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis. JACC Cardiovasc Imaging. 2009;2:1369e77.CrossRefGoogle Scholar
  42. 42.
    Porciani MC, Lilli A, Perfetto F, Cappelli F, Massimiliano Rao C, Del Pace S, et al. Tissue Doppler and strain imaging: a new tool for early detection of cardiac amyloidosis. Amyloid. 2009;16(2):63–70.CrossRefGoogle Scholar
  43. 43.
    • Plehn JF, Huntington M, Skinner M, Cohen A. Valvular regurgitation in primary amyloidosis: an early sign of cardiac involvement (abstr). Clin Res. 1988;36:308A This study explains the valvular involvement in the early stage of amyloidosis. Google Scholar
  44. 44.
    Plehn J, Dilsizian V, Skinner M, Cohen AS. Ventricular diastolic abnormalities in primary amyloidosis without obvious cardiac involvement (abstr). Circulation. 1986;74(suppl II):II-1800.Google Scholar
  45. 45.
    Hongo M, Fujii T, Jirayama J, et al. Radionuclide angiographic assessment of left ventricular diastolic filling in amyloid heart disease: a study of patients with familial amyloid polyneuropathy. J Am Coll Cardiol. 1989;13:4853.CrossRefGoogle Scholar
  46. 46.
    Plehn JF, Facc, Friedman BJ. Diastolic dysfunction in amyloid heart disease: restrictive cardiomyopathy or not? Editorial Comment JACC. 1989;13(I):6.Google Scholar
  47. 47.
    Di Bella G, Minutoli F, Madaffari A, Mazzeo A, Russo M, Donato R, et al. Left atrial function in cardiac amyloidosis. J Cardiovasc Med (Hagerstown). 2016;17(2):113–21.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Dalia Di Nunzio
    • 1
    Email author
  • Antonino Recupero
    • 1
  • Cesare de Gregorio
    • 1
  • Concetta Zito
    • 1
  • Scipione Carerj
    • 1
  • Gianluca Di Bella
    • 1
  1. 1.Clinical and Experimental Medicine Department, Cardiology UnitUniversity of MessinaMessinaItaly

Personalised recommendations